EASL Recognition Award Recipient 2023: Prof. Julia A. Wendon von Heneghan, Michael A.

Volltext

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA von Schattenberg, Jörn M., Pares, Albert, Kowdley, Kris V., Heneghan, Michael A., Caldwell, Stephen, Pratt, Daniel, Bonder, Alan, Hirschfield, Gideon M., Levy, Cynthia, Vierling, John, Jones, David, Tailleux, Anne, Staels, Bart, Megnien, Sophie, Hanf, Remy, Magrez, David, Birman, Pascal, Luketic, Velimir

Volltext

British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis von Gleeson, Dermot, Heneghan, Michael A

Volltext

Acute Severe Autoimmune Hepatitis: Corticosteroids or Liver Transplantation? von Rahim, Mussarat N., Liberal, Rodrigo, Miquel, Rosa, Heaton, Nigel D., Heneghan, Michael A.

Volltext

Autoimmune hepatitis von Heneghan, Michael A, Dr, Yeoman, Andrew D, MB, Verma, Sumita, MD, Smith, Alastair D, MD, Longhi, Maria Serena, PhD

Volltext

Autoimmune hepatitis in pregnancy: Pearls and pitfalls von Chung, Y. Y., Heneghan, Michael A.

Volltext

Liver disease in pregnancy von Joshi, Deepak, MRCP, James, Andra, MD, Quaglia, Alberto, FRCPath, Westbrook, Rachel H, MRCP, Heneghan, Michael A, Dr

Volltext

Systematic review with meta‐analysis: outcomes of pregnancy in patients with autoimmune hepatitis von Si, Tengfei, Huang, Zhenlin, Hegarty, Robert, Ma, Yun, Heneghan, Michael A.

Volltext

Hepatic manifestations of hereditary haemorrhagic telangiectasia von Kelly, Claire, Buscarini, Elisabetta, Manfredi, Guido, Gregory, Stephen, Heneghan, Michael A.

Volltext

T helper cell immunity in pregnancy and influence on autoimmune disease progression von Graham, Jonathon J., Longhi, Maria Serena, Heneghan, Michael A.

Volltext

Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid von Carbone, Marco, Mells, George F, Pells, Greta, Dawwas, Muhammad F, Newton, Julia L, Heneghan, Michael A, Neuberger, James M, Day, Darren B, Ducker, Samantha J, Sandford, Richard N, Alexander, Graeme J, Jones, David E.J

Volltext

Evaluation of coronary artery disease in potential liver transplant recipients von Hogan, Brian J., Gonsalkorala, Enoka, Heneghan, Michael A.

Volltext

Epstein–Barr virus status and immunosuppression use in paediatric autoimmune liver disease von Nayagam, Jeremy S., Heneghan, Michael A., Samyn, Marianne, Joshi, Deepak

Volltext

Low‐Dose Interleukin‐2 for Refractory Autoimmune Hepatitis von Lim, Tiong Y., Martinez‐Llordella, Marc, Kodela, Elisavet, Gray, Elisabeth, Heneghan, Michael A., Sanchez‐Fueyo, Alberto

Volltext

Con: Steroids Should Not Be Withdrawn in Transplant Recipients With Autoimmune Hepatitis von Theocharidou, Eleni, Heneghan, Michael A.

Volltext

Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates von Candels, Lena S., Rahim, Mussarat N., Shah, Sital, Heneghan, Michael A.

Volltext

The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility von Wong, Lin Lee, Fisher, Holly F, Stocken, Deborah D, Rice, Stephen, Khanna, Amardeep, Heneghan, Michael A, Oo, Ye Htun, Mells, George, Kendrick, Stuart, Dyson, Jessica Katharine, Jones, David E. J.

Volltext

Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome von Yeoman, Andrew D, Westbrook, Rachel H, Zen, Yoh, Bernal, William, Al-Chalabi, Thawab, Wendon, Julia A, O’Grady, John G, Heneghan, Michael A

Volltext

Reply to: “The search for optimum thiopurine metabolite levels in autoimmune hepatitis continues…” von Rahim, Mussarat N., Heneghan, Michael A.

Volltext

Approach to the patient with acute severe autoimmune hepatitis von Rahim, Mussarat N., Miquel, Rosa, Heneghan, Michael A.

Volltext